Last reviewed · How we verify
Hormone replacement cycle in embryo transfer — Treatment Landscape & Competitive Intelligence
1 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| Estrace | ESTRADIOL | Pfizer | Estrogen | Estrogen receptor | 1975-01-01 |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
- — Estring · FDA · approved · US
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- Pfizer · 1 drug in Hormone replacement cycle in embryo transfer
- Pfizer Inc. · 1 drug in Hormone replacement cycle in embryo transfer
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in Hormone replacement cycle in embryo transfer:
- Hormone replacement cycle in embryo transfer treatment updates — RSS
- Hormone replacement cycle in embryo transfer treatment updates — Atom
- Hormone replacement cycle in embryo transfer treatment updates — JSON
Cite this brief
Drug Landscape (2026). Hormone replacement cycle in embryo transfer — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/hormone-replacement-cycle-in-embryo-transfer. Accessed 2026-06-10.
Related
- Hormone replacement cycle in embryo transfer full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing